NDUFS6 Gene

NDUFS6 Gene

Overview

NDUFS6 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NDUFS6 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>NDUFS6</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>NADH:Ubiquinone Oxidoreductase Core Subunit S6</td>
</tr>
<tr>
<td class="label">Alternative Name</td>
<td>TYKY</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>5p14.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>4729</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>602152</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000145494</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>O75306</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Complex I subunit family (NADH dehydrogenase)</td>
</tr>
<tr>
<td class="label">Length</td>
<td>124 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~13 kDa</td>
</tr>
<tr>
<td class="label">Complex</td>
<td>Name</td>
</tr>
<tr>
<td class="label">I</td>
<td>NADH:ubiquinone oxidoreductase</td>
</tr>
<tr>
<td class="label">II</td>
<td>Succinate:ubiquinone oxidoreductase</td>
</tr>
<tr>
<td class="label">III</td>
<td>Cytochrome bc1 complex</td>
</tr>
<tr>
<td class="label">IV</td>
<td>Cytochrome c oxidase</td>
</tr>
<tr>
<td class="label">V</td>
<td>ATP synthase</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">CoQ10 supplementation</td>
<td>Clinical</td>
</tr>
<tr>
<td class="label">Mitochondrial agents</td>
<td>Various</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">13 edges</a></td>
</tr>
</table>

NDUFS6 (NADH:Ubiquinone Oxidoreductase Core Subunit S6), also known as TYKY, is a critical iron-sulfur subunit of mitochondrial complex I (NADH:ubiquinone oxidoreductase), the largest enzyme of the mitochondrial electron transport chain. Complex I is essential for oxidative phosphorylation, catalyzing the transfer of electrons from NADH to ubiquinone while pumping protons across the inner mitochondrial membrane to generate the electrochemical gradient used for ATP synthesis. NDUFS6 contains iron-sulfur clusters that are essential for electron transfer, and mutations in this gene cause severe mitochondrial diseases including Leigh syndrome, mitochondrial complex I deficiency, and contribute to more common neurodegenerative conditions such as Parkinson's disease["@loeffen2001"].

Gene Information

Molecular Function

Complex I Structure

Mitochondrial complex I (NADH:ubiquinone oxidoreductase) is the largest respiratory chain complex, comprising 44 subunits organized into:

• Hydrophobic arm: Embedded in the inner mitochondrial membrane
• Peripheral arm: Extends into the mitochondrial matrix
• Core subunits: 14 essential "economical" subunits conserved from bacteria to humans
• Supernumerary subunits: 30 additional subunits in mammals

Iron-Sulfur Clusters

NDUFS6 contains essential iron-sulfur (Fe-S) clusters for electron transfer:

• 2Fe-2S cluster: Primary electron acceptor from NADH
• 4Fe-4S cluster: Electron transfer to ubiquinone

Electron Transfer Chain

Complex I catalyzes:

This creates the proton gradient that drives ATP synthase (complex V) to produce ATP.

Role in Neurodegeneration

Leigh Syndrome

Recessive mutations in NDUFS6 cause classic Leigh syndrome (subacute necrotizing encephalomyelopathy)[@loeffen2001]:

Clinical Features:

• Progressive neurodegeneration affecting brainstem, basal ganglia, and thalamus
• Onset in infancy or early childhood (typically 3-18 months)
• Developmental regression, loss of milestones
• Ataxia, dystonia, hypotonia
• Respiratory failure, seizures
• Optical atrophy, hearing loss

• Elevated lactate in blood and CSF
• MRI: symmetric T2 hyperintensities in putamen, brainstem
• Severe complex I deficiency (<20% residual activity)
• Poor prognosis, often fatal within 2 years

• NDUFS6 mutations reduce complex I assembly/stability
• Impaired NADH oxidation leads to energy failure
• Accumulated NADH drives anaerobic metabolism
• Lactate acidosis and cell death

Mitochondrial Complex I Deficiency

NDUFS6 mutations cause isolated complex I deficiency[@berger2008]:

• Heterogeneous presentation: From severe encephalopathy to mild myopathy
• Tissue specificity: Brain, heart, muscle most affected
• Energy crisis: Reduced ATP production in high-demand tissues
• Oxidative stress: Electron leak increases ROS production

Parkinson's Disease

Complex I dysfunction is a hallmark of PD:

Alzheimer's Disease

Complex I involvement in AD:

• Reduced complex I activity in AD brain
• Amyloid-beta directly inhibits complex I
• Mitochondrial dysfunction precedes clinical symptoms
• NDUFS6 expression altered in AD

Mitochondrial Electron Transport Chain

Overview

The mitochondrial electron transport chain (ETC) consists of four complexes:

Complex I Architecture

Complex I contains:

• N module (NADH dehydrogenase): NADH binding and oxidation
• Q module (Quinone reduction): Ubiquinone reduction site
• P module (Proton pumping): Translocation of 4 H+ per NADH

Therapeutic Approaches

Current Strategies

Emerging Therapies

• Gene therapy: AAV delivery of functional NDUFS6
• Small molecules: Complex I assembly stabilizers
• mTOR inhibitors: Modulate metabolic stress
• Antioxidants: Mitigate oxidative stress

Mitochondrial Replacement Therapy

• Three-parent IVF: Germline mitochondrial replacement
• MRT for Leigh syndrome: Clinical trials ongoing
• Ethical considerations: Germline modification debates

Expression Patterns

Tissue Distribution

NDUFS6 is ubiquitously expressed, with highest levels in:

• Brain: Cerebral cortex, cerebellum, spinal cord
• Heart: Left ventricle (high energy demand)
• Skeletal muscle: Type I fibers
• Liver: Hepatocytes
• Kidney: Tubular cells

Cellular Localization

• Mitochondrial matrix: Integral to complex I structure
• Inner mitochondrial membrane: Peripheral arm
• Neuronal soma: High density in perikarya
• Synaptic terminals: Mitochondria-rich

Structure and Assembly

Protein Structure

NDUFS6 is a small protein with:

• N-terminal region: Contains Fe-S binding motifs (Cys-XX-Cys-XX-Cys)
• C-terminal region: Interacts with other complex I subunits
• Co-factor binding: Requires Fe-S cluster assembly machinery

Assembly Factors

Proper complex I assembly requires:

• NDUFAF1-6: Assembly factors
• NFU1, BOLA3: Fe-S cluster assembly
• LYRM proteins: Lipoyl-binding assembly factors
• NDUFS6 mutations: Can affect assembly efficiency

Clinical Relevance

Diagnosis

• Genetic testing: Targeted NDUFS6 sequencing
• Biochemical testing: Complex I activity in musclefibroblasts
• Newborn screening: Some regions include mitochondrial disease panels
• Prenatal testing: For known familial mutations

Prognosis

• Leigh syndrome: Poor prognosis, early mortality
• Isolated deficiency: Variable, depends on residual activity
• Adult-onset: Generally more benign

Research Directions

Current research focuses on:

• Complex I structure determination[@davies2018]
• NDUFS6 mutation spectrum and genotype-phenotype correlation
• Gene therapy approaches
• Mitochondrial replacement therapy
• Biomarker development for disease progression

NDUFS6 in Specific Brain Regions

Substantia Nigra

In substantia nigra:

• High metabolic demand
• Complex I vulnerability in PD
• Dopaminergic neuron susceptibility
• Therapeutic implications

Hippocampus

In hippocampus:

• Memory circuit functions
• Complex I in synaptic plasticity
• AD pathology involvement
• Energy metabolism

Cerebral Cortex

In cortex:

• Pyramidal neuron energy needs
• Complex I expression
• Cortical dysfunction in disease

Cerebellum

In cerebellum:

• Motor coordination
• Purkinje cell energy demands
• Ataxia associations

NDUFS6 and Protein Aggregation

Amyloid Pathology

In AD:

• Aβ inhibits complex I
• Mitochondrial dysfunction amplification
• Synaptic energy failure
• Therapeutic implications

Tau Pathology

In tauopathies:

• Mitochondrial dysfunction in tauopathy
• NDUFS6 in neuronal survival
• Energy crisis mechanisms

Alpha-Synuclein

In PD:

• Complex I in dopaminergic neurons
• Alpha-synuclein effects on mitochondria
• Energy failure

NDUFS6 in Glial Cells

Microglial NDUFS6

• Energy requirements for activation
• Inflammatory responses
• Neuroprotection roles

Astrocytic NDUFS6

• Metabolic support
• Mitochondrial function
• Astrocyte-neuron coupling

Oligodendrocyte NDUFS6

• Myelin energy demands
• White matter involvement

NDUFS6 and Synaptic Function

Synaptic Energy

• High energy demand
• ATP supply for neurotransmission
• Complex I role

Synaptic Dysfunction

• Energy failure
• Synaptic loss mechanisms
• Cognitive decline

NDUFS6 in Animal Models

Mouse Models

• Ndufs6 knockout: Embryonic lethal
• Conditional knockouts: Tissue-specific
• Transgenics: Disease models

Phenotypic Findings

• Complex I deficiency
• Metabolic dysfunction
• Neurological phenotypes

NDUFS6 and Cellular Stress

Oxidative Stress

• ROS production
• Antioxidant systems
• Damage mechanisms

ER Stress

• Mitochondrial-uploading stress
• Unfolded protein response
• [Apoptosis](/mechanisms/apoptosis)

Metabolic Stress

• Energy failure
• Glucose metabolism
• Therapeutic implications

NDUFS6 as Biomarker

Genetic Testing

• Mutation analysis
• Newborn screening
• Carrier detection

Protein Biomarkers

• Complex I activity
• Mitochondrial function
• Disease monitoring

Therapeutic Strategies

Current Approaches

Challenges

• Brain delivery
• Specificity
• Timing
• Efficacy

Opportunities

• Early intervention
• Combination approaches
• Personalized medicine

NDUFS6 and Blood-Brain Barrier

BBB Transport

• Mitochondrial agents
• Delivery challenges

BBB in Disease

• Dysfunction in neurodegeneration
• Therapeutic implications

NDUFS6 and Aging

Age-Related Changes

• Declining complex I activity
• Mitochondrial dysfunction
• Cognitive decline

Interventions

• Antioxidants
• Exercise
• Mitochondrial support

NDUFS6 and Metabolic Disease

Diabetes

• Metabolic dysfunction
• Neurodegeneration links
• Therapeutic implications

Obesity

• Metabolic effects
• Brain energy metabolism

Clinical Trials

Ongoing Trials

• CoQ10 in PD
• Mitochondrial agents
• Gene therapy approaches

Results

• Variable efficacy
• Safety data
• Biomarker findings

Research Methods

Complex I Analysis

• Blue-native PAGE
• Enzymatic assays
• Structure studies

Cellular Models

• Patient fibroblasts
• iPSC-derived neurons
• Mitochondrial studies

Cross-Links

• [Mitochondrial Electron Transport Chain](/mechanisms/mitochondrial-electron-transport-chain)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction-neurodegeneration)
• [Leigh Syndrome](/diseases/leigh-syndrome)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Complex I Deficiency](/diseases/mitochondrial-complex-i-deficiency)

See Also

• [Oxidative Phosphorylation](/mechanisms/oxidative-phosphorylation)
• [Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics)
• [ROS and Neurodegeneration](/mechanisms/ros-neurodegeneration)
• [Energy Metabolism in Brain](/mechanisms/brain-energy-metabolism)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving NDUFS6 Gene discovered through SciDEX knowledge graph analysis: